A Risk Model Using Refined Disease Risk Index and 1-Month NK-Cell Count for Relapse in Children and Adults with T-ALL/LBL After Myeloablative Umbilical Cord Blood Transplantation
Na Zhao,1– 4,* Rong Chi,1,3,4,* Kaidi Song,1,3,4,* Yue Wu,1,3,4 Bingbing Yan,1,3,4 Dongyao Wang,1,3,4 Baolin Tang,1,3,4 Xiaoyu Zhu1,3,4 1Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technolo...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Dove Medical Press
2026-05-01
|
| Ráidu: | Blood and Lymphatic Cancer: Targets and Therapy |
| Fáttát: | |
| Liŋkkat: | https://www.dovepress.com/a-risk-model-using-refined-disease-risk-index-and-1-month-nk-cell-coun-peer-reviewed-fulltext-article-BLCTT |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
